Login
Toggle sidebar

Lint: prostate-specific-membrane-antigen

prostate-specific-membrane-antigen
Acronyms
warning

"Prostate-specific membrane antigen (PSMA), also known as glutamate carboxypeptidase II, is a type II transmembrane glycoprotein that has become an increasingly prominent imaging biomarker 1. PSMA has emerged as a useful target in PET imaging of prostate cancer, especially in the evaluation of small volume lymph node and bone metastases using tracers like Ga-68 PSMA (the first radiotracer to be approved by the FDA in December 2020) and F-18 PSMA 2,11. The theranostic agent Lutetium-177 vipivotide tetraxetan (trade name Pluvicto) used to treat metastatic castration-resistant prostate cancer obtained FDA approval in 2022 12."

Line 1:493 · 'FDA' has no definition. Spell it out if it's unfamiliar to the audience.

"Prostate-specific membrane antigen (PSMA), also known as glutamate carboxypeptidase II, is a type II transmembrane glycoprotein that has become an increasingly prominent imaging biomarker 1. PSMA has emerged as a useful target in PET imaging of prostate cancer, especially in the evaluation of small volume lymph node and bone metastases using tracers like Ga-68 PSMA (the first radiotracer to be approved by the FDA in December 2020) and F-18 PSMA 2,11. The theranostic agent Lutetium-177 vipivotide tetraxetan (trade name Pluvicto) used to treat metastatic castration-resistant prostate cancer obtained FDA approval in 2022 12."

Line 1:703 · 'FDA' has no definition. Spell it out if it's unfamiliar to the audience.
Headings Valid
warning

Expected headings

  • H1 Terminology
  • H1 Usage
  • H1 Epidemiology
  • H2 Risk factors
  • H2 Associations
  • H1 Clinical presentation
  • H2 Complications
  • H1 Diagnosis
  • H2 Diagnostic criteria
  • H2 Diagnostic clues
  • H1 Pathology
  • H2 Aetiology
  • H2 Location
  • H2 Classification
  • H2 Macroscopic appearance
  • H2 Microscopic appearance
  • H2 Immunophenotype
  • H2 Markers
  • H2 Genetics
  • H1 Radiographic features
  • H2 Plain radiograph
  • H2 Mammography
  • H2 Antenatal ultrasound
  • H2 Transoesophageal echocardiography
  • H2 Ultrasound
  • H2 CT
  • H3 Dual-energy CT
  • H2 Angiography (DSA)
  • H2 MRI
  • H2 CT/MRI
  • H2 Nuclear medicine
  • H3 PET-CT
  • H3 PET-MRI
  • H1 Radiology report
  • H1 Treatment and prognosis
  • H2 Complications
  • H1 History and etymology
  • H1 Differential diagnosis
  • H2 Clinical differential diagnosis
  • H1 Practical points
  • H1 See also

"Advantages"

Line 3:1 · "Advantages" is not a recognised heading for this article type.

"Disadvantages"

Line 10:1 · "Disadvantages" is not a recognised heading for this article type.
Links
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
6
2